PM
AMED

Pembroke Management’s Amedisys AMED Stock Holding History

Pembroke Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-41,070
Closed -$12M – 66
2020
Q4 		$12M Sell
41,070
-20,370
-33% -$5.22M 1.01% 47
2020
Q3 		$14.5M Sell
61,440
-168
-0.3% -$38.2K 1.58% 30
2020
Q2 		$12.2M Sell
61,608
-1,126
-2% -$210K 1.44% 33
2020
Q1 		$11.5M Sell
62,734
-4,493
-7% -$799K 1.83% 25
2019
Q4 		$11.2M Buy
67,227
+15,359
+30% +$2.28M 0.95% 49
2019
Q3 		$6.79M Buy
+51,868
New +$6.75M 0.74% 45

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Pembroke Management's AMED Position: Q1 2021 in Review

Pembroke Management sold out of Amedisys (AMED) in Q1 2021, closing a stake of 41,070 shares — an estimated $12M sold.

Pembroke Management first reported a position in AMED in Q3 2019 and held it in 6 quarters. The position peaked at $14.5M in Q3 2020. 389 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

  • Pembroke Management reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
  • Pembroke Management sold 41,070 Amedisys shares in Q1 2021, an estimated $12M.
  • Pembroke Management first reported a position in Amedisys in Q3 2019 and held it in 6 quarters.
  • Pembroke Management's Amedisys position peaked at $14.5M in Q3 2020.
  • 389 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on Pembroke Management's 13F filing for Q1 2021, filed 6 May 2021.